RxDoctor Payments Data

Rahima Afghan, MD

Psychiatry · Murrieta, CANPI 1023060449

Payments from drug & device makers

$5,876in general payments, 2019–2025

Across 326 payments — averaging $18.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$882
  • AbbVie$869
  • Takeda Pharmaceuticals U.S.A., Inc.$594
  • Sunovion Pharmaceuticals Inc.$522
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$473
  • Neurocrine Biosciences, Inc.$398
  • plus $2K from 16 others

What the payments were for

  • Food & beverage$5,876100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,876 in reported general payments places this provider in the 90th percentile of 4,954 psychiatry providers in California.

See all psychiatry providers in California

Medicare billing

Part B allowed, 2024
$52,035
Medicare patients
120
Services billed
535

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate22$57,714
Aripiprazole121$17,842
Quetiapine Fumarate ErQuetiapine Fumarate37$4,574
Lurasidone Hcl26$3,348
Quetiapine Fumarate138$2,733
Oxcarbazepine110$2,658
Escitalopram Oxalate224$1,935
Risperidone116$1,909
Trazodone Hcl222$1,882
Ziprasidone Hcl51$1,850
Bupropion XlBupropion Hcl77$1,765
Venlafaxine Hcl ErVenlafaxine Hcl59$1,608
Hydroxyzine Hcl138$1,585
Atomoxetine Hcl22$1,474
Olanzapine131$1,456

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$387$57,71422 claims
Almatica Pharma LLCSertraline Hcl$18$1,149198 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,954 psychiatry providers in California.

Other psychiatry in Murrieta

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →